Browse by category

Medtech giants, Medtronic and Stryker, have announced strategic investments in Cornerstone Robotics and CMR Surgical (CMR), respectively, as the companies seek to consolidate their positions in the robotic surgery market. Cornerstone Robotics' Sentire surgical system In early September, Medtronic revealed they had signed a strategic partnership with Cornerstone Robotics, in which Medtronic made an approximately $700 million investment includes rights to distribute Cornerstone

The World Health Organization (WHO) has released its first guidelines addressing the sharp rise in obesity among children and adolescents, setting out how health systems and health workers can deliver timely, evidence-based and people-centred care. In the guidelines, WHO does not recommend pharmacological treatment, bariatric surgery or weight-loss devices for children aged 0–9 years. In 2024, 170 million children and adolescents aged 5–19 years were living with obesity, incl

The second of a series of papers presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2), presenters discussed the wide-ranging issues relating to use of GLP-1 RA drug use in women. The paper’s authors, including Professor Paul Franks, Lund University, Helsingborg Hospital, Helsingborg, Sweden and Professor Claire Meek, Leicester Diabetes Research Centre and Leicester NIHR Biomedical Research Centre, Leice

There is no link between semaglutide (a glucagon-like peptide-1 receptor agonist, GLP-1RA) use and pancreatic cancer using nationwide registry data from Denmark, Sweden and Norway, according to at the Annual Meeting of The European Association for the Study of Diabetes (EASD). This regulator-mandated post authorisation study, funded by Novo Nordisk, was presented by Professor Anton Pottegård, University of Southern Denmark, Odense, Denmark, and colleagues. “This comprehensive

In a career spanning decades, Professor Michel Gagner (Professor of Surgery in Montreal, Canada) has consistently pushed the boundaries of minimally invasive surgery. His lifelong dedication to surgical education was recently celebrated in Chicago, where he was inducted into the prestigious American College of Surgeons (ACS) Academy of Master Surgeon Educators. Michel Gagner Founded by Dr Ajit Sachdeva, this highly selective academy includes fewer than 250 surgeons out of 100

The FDA has cleared Medtronic’s LigaSure robotic-assisted surgery (RAS) Maryland jaw device for use with the Hugo RAS system. The clearance expands the instruments available on the Hugo RAS system and brings Medtronic's trusted vessel-sealing technology to US surgeons performing robotic-assisted procedures. LigaSure robotic-assisted surgery Maryland jaw device As robotic-assisted surgery adoption grows in the US, surgeons increasingly expect the same trusted energy instrument

PlacidWay, a global medical tourism platform, has released industry research examining how the rapid adoption of non-surgical medications is influencing international healthcare travel patterns, including changing demand for bariatric surgery and increased interest in post-bariatric aesthetic care. The analysis identifies a shift in the traditional medical tourism pathway, particularly in medical tourism for bariatric surgery, as some patients who previously considered travel

Results from Syntis Bio’s 28-day multiple ascending dose (MAD) portion of its Phase 1/1b SYNTIETY-1 clinical trial, evaluating SYNT-101 as a potential treatment of obesity, revealed that SYNT-101 was well tolerated at all dose levels in the MAD cohorts (n=23), with no discontinuations and no dose reductions in any of the cohorts. SYNT-101 is being developed as a once-daily pill for the treatment of obesity. SYNT-101 works by transiently blocking nutrient absorption in the pro

Dr Jaime Ponce has officially assumed the presidency of the International Federation for the Surgery and Other Therapies for Obesity (IFSO) during the closing ceremony of the XXIX IFSO World Congress in Toronto. Ponce received the leadership of the Federation from outgoing President, Dr Khaled Gawdat of Egypt, whom he recognised for his dedicated service and important contributions to IFSO and the global obesity-care community. "It is a tremendous honour to serve as President

A new Scientific Statement released by the Endocrine Society highlights the benefits of obesity treatment beyond weight loss, including improvements in overall health and reducing the risk of conditions such as heart disease, sleep apnoea and liver disease. Obesity is a complex, chronic disease influenced by biology, genetics, metabolism, the brain, and environmental factors, not simply a matter of willpower. The disease affects over 40% of American adults and costs over $173